Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.

BACKGROUND:Erectile dysfunction is an emerging risk marker for future cardiovascular disease (CVD) events; however, evidence on dose response and specific CVD outcomes is limited. This study investigates the relationship between severity of erectile dysfunction and specific CVD outcomes. METHODS AND...

Full description

Bibliographic Details
Main Authors: Emily Banks, Grace Joshy, Walter P Abhayaratna, Leonard Kritharides, Peter S Macdonald, Rosemary J Korda, John P Chalmers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC3558249?pdf=render
id doaj-9d09bb70c743456ba055f4799f05a9b1
record_format Article
spelling doaj-9d09bb70c743456ba055f4799f05a9b12020-11-24T21:55:55ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762013-01-01101e100137210.1371/journal.pmed.1001372Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.Emily BanksGrace JoshyWalter P AbhayaratnaLeonard KritharidesPeter S MacdonaldRosemary J KordaJohn P ChalmersBACKGROUND:Erectile dysfunction is an emerging risk marker for future cardiovascular disease (CVD) events; however, evidence on dose response and specific CVD outcomes is limited. This study investigates the relationship between severity of erectile dysfunction and specific CVD outcomes. METHODS AND FINDINGS:We conducted a prospective population-based Australian study (the 45 and Up Study) linking questionnaire data from 2006-2009 with hospitalisation and death data to 30 June and 31 Dec 2010 respectively for 95,038 men aged ≥45 y. Cox proportional hazards models were used to examine the relationship of reported severity of erectile dysfunction to all-cause mortality and first CVD-related hospitalisation since baseline in men with and without previous CVD, adjusting for age, smoking, alcohol consumption, marital status, income, education, physical activity, body mass index, diabetes, and hypertension and/or hypercholesterolaemia treatment. There were 7,855 incident admissions for CVD and 2,304 deaths during follow-up (mean time from recruitment, 2.2 y for CVD admission and 2.8 y for mortality). Risks of CVD and death increased steadily with severity of erectile dysfunction. Among men without previous CVD, those with severe versus no erectile dysfunction had significantly increased risks of ischaemic heart disease (adjusted relative risk [RR] = 1.60, 95% CI 1.31-1.95), heart failure (8.00, 2.64-24.2), peripheral vascular disease (1.92, 1.12-3.29), "other" CVD (1.26, 1.05-1.51), all CVD combined (1.35, 1.19-1.53), and all-cause mortality (1.93, 1.52-2.44). For men with previous CVD, corresponding RRs (95% CI) were 1.70 (1.46-1.98), 4.40 (2.64-7.33), 2.46 (1.63-3.70), 1.40 (1.21-1.63), 1.64 (1.48-1.81), and 2.37 (1.87-3.01), respectively. Among men without previous CVD, RRs of more specific CVDs increased significantly with severe versus no erectile dysfunction, including acute myocardial infarction (1.66, 1.22-2.26), atrioventricular and left bundle branch block (6.62, 1.86-23.56), and (peripheral) atherosclerosis (2.47, 1.18-5.15), with no significant difference in risk for conditions such as primary hypertension (0.61, 0.16-2.35) and intracerebral haemorrhage (0.78, 0.20-2.97). CONCLUSIONS:These findings give support for CVD risk assessment in men with erectile dysfunction who have not already undergone assessment. The utility of erectile dysfunction as a clinical risk prediction tool requires specific testing.http://europepmc.org/articles/PMC3558249?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Emily Banks
Grace Joshy
Walter P Abhayaratna
Leonard Kritharides
Peter S Macdonald
Rosemary J Korda
John P Chalmers
spellingShingle Emily Banks
Grace Joshy
Walter P Abhayaratna
Leonard Kritharides
Peter S Macdonald
Rosemary J Korda
John P Chalmers
Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
PLoS Medicine
author_facet Emily Banks
Grace Joshy
Walter P Abhayaratna
Leonard Kritharides
Peter S Macdonald
Rosemary J Korda
John P Chalmers
author_sort Emily Banks
title Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
title_short Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
title_full Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
title_fullStr Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
title_full_unstemmed Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
title_sort erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2013-01-01
description BACKGROUND:Erectile dysfunction is an emerging risk marker for future cardiovascular disease (CVD) events; however, evidence on dose response and specific CVD outcomes is limited. This study investigates the relationship between severity of erectile dysfunction and specific CVD outcomes. METHODS AND FINDINGS:We conducted a prospective population-based Australian study (the 45 and Up Study) linking questionnaire data from 2006-2009 with hospitalisation and death data to 30 June and 31 Dec 2010 respectively for 95,038 men aged ≥45 y. Cox proportional hazards models were used to examine the relationship of reported severity of erectile dysfunction to all-cause mortality and first CVD-related hospitalisation since baseline in men with and without previous CVD, adjusting for age, smoking, alcohol consumption, marital status, income, education, physical activity, body mass index, diabetes, and hypertension and/or hypercholesterolaemia treatment. There were 7,855 incident admissions for CVD and 2,304 deaths during follow-up (mean time from recruitment, 2.2 y for CVD admission and 2.8 y for mortality). Risks of CVD and death increased steadily with severity of erectile dysfunction. Among men without previous CVD, those with severe versus no erectile dysfunction had significantly increased risks of ischaemic heart disease (adjusted relative risk [RR] = 1.60, 95% CI 1.31-1.95), heart failure (8.00, 2.64-24.2), peripheral vascular disease (1.92, 1.12-3.29), "other" CVD (1.26, 1.05-1.51), all CVD combined (1.35, 1.19-1.53), and all-cause mortality (1.93, 1.52-2.44). For men with previous CVD, corresponding RRs (95% CI) were 1.70 (1.46-1.98), 4.40 (2.64-7.33), 2.46 (1.63-3.70), 1.40 (1.21-1.63), 1.64 (1.48-1.81), and 2.37 (1.87-3.01), respectively. Among men without previous CVD, RRs of more specific CVDs increased significantly with severe versus no erectile dysfunction, including acute myocardial infarction (1.66, 1.22-2.26), atrioventricular and left bundle branch block (6.62, 1.86-23.56), and (peripheral) atherosclerosis (2.47, 1.18-5.15), with no significant difference in risk for conditions such as primary hypertension (0.61, 0.16-2.35) and intracerebral haemorrhage (0.78, 0.20-2.97). CONCLUSIONS:These findings give support for CVD risk assessment in men with erectile dysfunction who have not already undergone assessment. The utility of erectile dysfunction as a clinical risk prediction tool requires specific testing.
url http://europepmc.org/articles/PMC3558249?pdf=render
work_keys_str_mv AT emilybanks erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
AT gracejoshy erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
AT walterpabhayaratna erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
AT leonardkritharides erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
AT petersmacdonald erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
AT rosemaryjkorda erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
AT johnpchalmers erectiledysfunctionseverityasariskmarkerforcardiovasculardiseasehospitalisationandallcausemortalityaprospectivecohortstudy
_version_ 1725860574676385792